. 2015 Sep 25;20(10):17760–17774. doi: 10.3390/molecules201017760

Table 3.

Contents of total hydroxycinnamic acids and rosmarinic acid (330 nm) of Infusions A–C, as well as flavan-3-ols (270 nm) and (−)-epicatechin of infusions D and E (mg/100 mg dry infusion) before and after simulated digestion.

Infusion	Before Digestion	After Digestion	% Bioaccessibility ^a
mg/100 mg dry infusion ^a,b
	Total hydroxycinnamic acids ^c/rosmarinic acid (330 nm)
A	3.09 ± 0.02 ^a/1.53 ± 0.04 ^a	2.71 ± 0.14 ^a/1.09 ± 0.03 ^b	87.6 ± 4.1/71.4 ± 2.9
B	2.70 ± 0.01 ^a/1.92 ± 0.03 ^a	2.12 ± 0.30 ^b/1.76 ± 0.07 ^a	78.6 ± 10.8/91.9 ± 3.2
C	2.44 ± 0.06 ^a/1.57 ± 0.04 ^a	2.09 ± 0.41 ^b/1.71 ± 0.02 ^a	86.2 ± 19.1/108.7 ± 3.9
	Total flavan-3-ols ^d/(−)-epicatechin (270 nm)
D	12.99 ± 0.27 ^a/12.23 ± 0.30 ^a	12.91 ± 0.60 ^a/10.68 ± 0.38 ^a	99.3 ± 2.2/87.3 ± 1.3
E	19.47 ± 0.60 ^a/13.89 ± 0.26 ^a	18.35 ± 0.30 ^a/12.60 ± 0.16 ^a	94.3 ± 2.9/90.8 ± 1.5

^a Values are expressed as the mean ± SD; ^b different lower case letters within the same row for each infusion tested before and after digestion indicate significant differences according to Duncan’s test at p < 0.05; ^c expressed as rosmarinic acid equivalents; ^d expressed as (−)-epicatechin equivalents.